Home

Pfizer (PFE)

25.01
-0.20 (-0.79%)

Pfizer is a global biopharmaceutical company that develops and manufactures innovative medicines and vaccines to improve health outcomes for people around the world

Renowned for its extensive research and development efforts, Pfizer focuses on various therapeutic areas including vaccines, oncology, immunology, cardiology, endocrinology, and rare diseases. The company is committed to addressing significant health challenges through the discovery of new treatments, leveraging cutting-edge science and technology. Pfizer also emphasizes partnerships and collaborations to expand its capabilities and enhance access to healthcare solutions.

SummaryNewsPress ReleasesChartHistoricalFAQ
Pfizer: Value Play or Past Its Prime?fool.com
Via The Motley Fool · March 27, 2025
10 Best Dividend Stocks Trading Near 52-Week Lowstalkmarkets.com
Blue-chip stocks are established, financially strong, and consistently profitable publicly traded companies.
Via Talk Markets · March 27, 2025
What's going on in today's session: S&P500 most active stockschartmill.com
Looking for the most active stocks in the S&P500 index on Thursday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.
Via Chartmill · March 27, 2025
Japanese Drug Regulator Approves Genmab Cancer Drug For Patients With Advanced Cervical Cancerbenzinga.com
Genmab's Tivdak wins Japan's approval for advanced cervical cancer after a Phase 3 trial showed improved survival over chemotherapy.
Via Benzinga · March 27, 2025
Why Pfizer Is My Largest Healthcare Positionfool.com
Via The Motley Fool · March 27, 2025
Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals industry, including Pfizer (NYSE:PFE) and its peers.
Via StockStory · March 27, 2025
Pfizer Shares Are Down Today: What's Going On?benzinga.com
Pfizer shares are trading lower Wednesday after a Wall Street Journal report revealed that U.S. prosecutors are investigating a claim about the timing of Pfizer's COVID-19 vaccine announcement.
Via Benzinga · March 26, 2025
Most active S&P500 stocks in Wednesday's sessionchartmill.com
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Wednesday. Discover the stocks that are generating the highest trading volume and driving market activity.
Via Chartmill · March 26, 2025
FDA Approves Exelixis' Lead Cancer Drug Cabometyx For Expanded Use In Neuroendocrine Tumorsbenzinga.com
Exelixis' Cabometyx gains FDA approval for advanced neuroendocrine tumors, while phase 3 data confirms sustained survival benefits in renal cancer.
Via Benzinga · March 26, 2025
Looking for the most active stocks in the S&P500 index on Tuesday?chartmill.com
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.
Via Chartmill · March 25, 2025
China Courts Apple, Pfizer, Eli Lilly Amid US Pressure, Vice Premier Says Beijing 'Will Continue To Improve The Business Environment'benzinga.com
China is stepping up efforts to reassure U.S. corporate giants like Apple, Pfizer, and Mastercard of its economic potential, with Vice Premier He Lifeng promising a better business environment amid rising U.S. tariff pressures and slowing foreign investment.
Via Benzinga · March 23, 2025
Buying These Dirt-Cheap Stocks Could Be a Brilliant Movefool.com
Via The Motley Fool · March 22, 2025
Looking For Yields: Pfizer, Spire, And TriCo Bancshares Are Consistent Moneymakersbenzinga.com
Via Benzinga · March 21, 2025
Which Is The Healthiest Investment: Merck Or Pfizertalkmarkets.com
Adeep dive into Merck and Pfizer, two of the biggest pharmaceutical companies out there.
Via Talk Markets · March 21, 2025
10 Health Care Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · March 21, 2025
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressedbenzinga.com
UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI highlights declining UK R&D investment and falling global competitiveness.
Via Benzinga · March 21, 2025
Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBioinvestors.com
Alnylam added a gene silencer to the cardiomyopathy space this week, and will now rival Pfizer and BridgeBio.
Via Investor's Business Daily · March 21, 2025
32-Year-Old Investor With Massive NVDA Gains And $350K Cash Asks Reddit: 'What's Stopping Me From Putting It All In SCHD?'benzinga.com
Investors are often driven by the pursuit of massive gains and few assets capture this ambition better than individual stocks–like Nvidia Corporation (NASDAQ:
Via Benzinga · March 20, 2025
3 Reasons Pfizer Stock Could Be a Steal of a Deal in 2025fool.com
Via The Motley Fool · March 20, 2025
2 High-Yield Dividend Stocks That Are Bargain Buys Right Nowfool.com
Via The Motley Fool · March 20, 2025
1 Reliable Dividend Stock You Can Buy Now and Hold at Least a Decadefool.com
Via The Motley Fool · March 20, 2025
Curious about the most active S&P500 stocks in today's session?chartmill.com
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.
Via Chartmill · March 19, 2025
Pfizer Offloads Its Last 7% Stake In Consumer Health Haleon For Over $3 Billionbenzinga.com
Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock's unit is now Haleon's largest shareholder with over 5%.
Via Benzinga · March 19, 2025
Trump Administration Weighs Deep Cuts To Domestic HIV Prevention Programs, Gilead Stock Slidesbenzinga.com
HHS is considering major cuts to federal HIV prevention funding as part of a CDC reorganization, potentially affecting programs like PrEP. Experts warn the move could hinder efforts to combat the epidemic.
Via Benzinga · March 19, 2025
3 Dividend Stocks to Buy for Reliable Passive Incomefool.com
Via The Motley Fool · March 19, 2025